εὐκαιρία · “THE RIGHT MOMENT”
{{ h1a }} {{ h1b }}
Eukairia Therapeutics is developing a new generation of pharmaceutical products designed for the moments when treatment changes.
Medication transitions, redesigned.
Our patent-pending platform integrates drug delivery, behavioral science and human-centered design to make complex medication transitions simpler for patients and clinicians.
From treatment initiation and titration to tapering and therapeutic substitution, Eukairia is rethinking how pharmaceutical products support patients through change.
The hardest part of treatment is often the transition.
Starting a medication. Adjusting it. Changing therapies. Tapering treatment. Each transition can require multiple doses, instructions, decisions and patient actions.
Most pharmaceutical products are designed around the individual dose. Eukairia designs around the transition.
Built for change.
Eukairia is developing a therapeutic transition platform that brings medication delivery, sequencing and human-centered design together within the pharmaceutical product.
It is designed to support complex medication changes while reducing the decisions and actions traditionally placed on patients and clinicians.
INITIATE
Designed to simplify starting therapies that require structured changes in medication exposure.
TRANSITION
Supports planned changes in therapy, including titration and movement between treatments.
TAPER
Enables structured reductions in therapy without patients manually creating or managing complex dosing steps.
The transition is the product.
Instead of asking patients and clinicians to manually manage every step of a complex medication change, Eukairia is developing pharmaceutical systems in which more of the transition is designed into the product itself.
One platform. Multiple applications.
Every Eukairia program grows from a single patent-pending technology: the Therapeutic Transition Platform.
{{ p.t }}
{{ p.d }}
Not one drug. Not one disease.
Wherever a medication change takes multiple steps, the same challenge appears. Eukairia is building a platform for pharmaceutical transitions across therapeutic areas.
{{ a.d }}
Elizabeth Perkins, MD
Dr. Perkins is a Charleston-based physician, researcher and entrepreneur. She founded Eukairia Therapeutics in 2025, connecting frontline patient care and clinical insight with behavioral science to create a new paradigm in pharmaceutical design.
The company grew from a problem she encountered again and again in clinical medicine: highly effective medications can still be difficult to start, adjust, switch or stop. Some of that complexity should not have to be managed by the patient or clinician. It can be engineered into the pharmaceutical product.
She is the sole inventor on each of the company’s patent-pending technologies.
Eukairia means “the opportune moment.” For recovery, that moment is now.
Common questions.
What is Eukairia Therapeutics?
Eukairia Therapeutics is a Charleston, South Carolina pharmaceutical company founded in 2025 by Elizabeth Perkins, MD. It is developing pharmaceutical products designed for the moments when treatment changes.
What is the Therapeutic Transition Platform?
The Therapeutic Transition Platform is Eukairia’s patent-pending technology. It brings medication delivery, sequencing and human-centered design together within the pharmaceutical product to support complex medication changes.
What kinds of medication transitions does it address?
The platform is designed for treatment initiation, dose optimization and titration, therapeutic substitution, medication tapering, and transitions away from dependence-forming substances.
Which therapeutic areas could it apply to?
Potential applications include addiction medicine, psychiatry, pain and post-operative care, neurology, chronic disease and other treatments where a medication change requires multiple steps.
Are Eukairia’s products approved?
No. Eukairia’s products are in development and have not been approved or cleared by the U.S. Food and Drug Administration or any other regulatory authority.
How can I partner with Eukairia?
Eukairia welcomes conversations with pharmaceutical companies, health systems and development partners. Contact {{ mailText }} or use the form on this site.
Build the next generation of therapeutic transitions with us.
Eukairia is advancing its Therapeutic Transition Platform through internal development and strategic partnerships across pharmaceutical development, drug delivery, manufacturing and commercialization.
We welcome conversations with pharmaceutical companies, health systems and development partners where complex medication transitions remain a barrier to treatment.
Your message has been sent. We’ll follow up at {{ email }}.
Privacy Policy
This Privacy Policy explains how Eukairia Therapeutics (“Eukairia,” “we,” “us”) collects, uses and protects information when you visit eukairiatherapeutics.com (the “Site”) or contact us.
Information we collect
Information you provide. When you use our contact form or email us, we collect your name, organization, email address and anything you choose to include in your message.
Information collected automatically. Like most websites, the Site may collect technical data such as your IP address, browser type, device information, pages visited and referring website, through server logs, cookies and similar technologies.
We do not ask for, and you should not send us, personal health information through the Site.
How we use information
- To respond to inquiries, partnership requests and briefing requests
- To operate, maintain, secure and improve the Site
- To comply with legal obligations and protect our rights
We do not sell or rent your personal information, and we do not use it for targeted advertising.
How we share information
We share information only with service providers who help us operate the Site and communicate with you (such as hosting and email providers), under obligations to protect it; when required by law or legal process; or in connection with a merger, financing, acquisition or sale of assets.
Cookies
The Site may use cookies needed for it to function and, where permitted, analytics cookies to understand how it is used. You can control cookies through your browser settings.
Data retention and security
We keep personal information only as long as needed for the purposes above or as required by law, and use reasonable administrative, technical and physical safeguards to protect it. No method of transmission or storage is completely secure.
Your choices and rights
Depending on where you live, you may have the right to access, correct, delete or obtain a copy of your personal information, or to object to certain uses. To make a request, contact us at the address below. We will not discriminate against you for exercising these rights.
Children
The Site is not directed to children under 16, and we do not knowingly collect their personal information.
International visitors
The Site is operated in the United States. If you access it from elsewhere, your information will be processed in the United States.
Changes to this policy
We may update this policy from time to time. The effective date above shows when it was last revised.
Contact us
Eukairia Therapeutics · Charleston, South Carolina
{{ mailText }}
Terms of Use
These Terms of Use govern your use of eukairiatherapeutics.com (the “Site”), operated by Eukairia Therapeutics (“Eukairia,” “we,” “us”). By using the Site, you agree to these terms. If you do not agree, please do not use the Site.
Informational purposes only
Content on the Site is provided for general information about Eukairia and its technology. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Never change, start or stop a medication based on information on this Site.
Investigational technology
Eukairia’s products and platform are in development. They have not been approved or cleared by the U.S. Food and Drug Administration or any other regulatory authority, and no claims are made regarding their safety or effectiveness.
Forward-looking statements
The Site may contain statements about our plans, technology and development programs. These are based on current expectations, involve risks and uncertainties, and actual results may differ materially. We undertake no obligation to update them.
Intellectual property
The Site and its content — including text, graphics, logos and the Eukairia name — are owned by or licensed to Eukairia and protected by intellectual property laws. Eukairia’s technologies are the subject of pending patent applications. You may view and print Site content for personal, non-commercial use; any other use requires our prior written permission.
Your submissions
Please do not send confidential or proprietary information through the Site or by unsolicited email. Information you submit will not be treated as confidential unless we have agreed otherwise in a signed written agreement.
Acceptable use
You agree not to use the Site unlawfully, attempt to gain unauthorized access to it, interfere with its operation, or collect information from it by automated means.
Third-party links
The Site may link to third-party websites, such as LinkedIn. We are not responsible for their content or privacy practices.
Disclaimers and limitation of liability
The Site is provided “as is” and “as available,” without warranties of any kind. To the fullest extent permitted by law, Eukairia will not be liable for any indirect, incidental, consequential or punitive damages arising from your use of the Site.
Governing law
These terms are governed by the laws of the State of South Carolina, without regard to its conflict-of-law rules.
Changes
We may update these terms at any time. Continued use of the Site after changes are posted means you accept the revised terms.
Contact us
Eukairia Therapeutics · Charleston, South Carolina
{{ mailText }}
Accessibility Statement
Eukairia Therapeutics is committed to making eukairiatherapeutics.com accessible to everyone, including people with disabilities.
Our standard
We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.2, Level AA.
What we do
- Use sufficient color contrast for text and interface elements
- Provide text alternatives for meaningful images
- Support keyboard navigation and visible focus states
- Use clear headings and semantic structure for screen readers
- Design layouts that adapt to different screen sizes and zoom levels
Ongoing work
Accessibility is an ongoing effort. We review the Site as it changes and work to fix issues as they are identified. Some third-party content or tools linked from the Site may not be fully within our control.
Feedback
If you have difficulty accessing any part of the Site, or would like information in another format, please contact us. Tell us the page and the problem you encountered, and we will work to respond within five business days.
Eukairia Therapeutics · Charleston, South Carolina
{{ mailText }}